Abstract
Background: CHO-S cells produce non-anticoagulant heparan sulfate (HS) even when transfected with HS3st1 and NDST2. Results: Golgi targeting of HS3st1 alone in bioengineered CHO-S cells afforded anticoagulant HS. Conclusion: Targeting of HS3st1 to the Golgi ensured its action in biosynthesis and modified the action of other biosynthetic enzymes. Significance: Engineering the production of HS and potentially heparin could provide a safer form of this important anticoagulant drug.
Original language | English |
---|---|
Pages (from-to) | 37308-37318 |
Number of pages | 11 |
Journal | Journal of Biological Chemistry |
Volume | 288 |
Issue number | 52 |
DOIs | |
State | Published - 27 Dec 2013 |
Externally published | Yes |